Evidence map›Paper›PMID 40610748›Full record

ArticleScientific reports2025

A novel hybrid vision UNet architecture for brain tumor segmentation and classification.

M Renugadevi, K Narasimhan, K Ramkumar, N Raju

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M RenugadeviSchool of Electrical and Electronics Engineering, SASTRA Deemed University, Thanjavur, 613401, India.
K NarasimhanSchool of Electrical and Electronics Engineering, SASTRA Deemed University, Thanjavur, 613401, India. knr@ece.sastra.edu.
K RamkumarSchool of Computing, SASTRA Deemed University, Thanjavur, 613401, India.
N RajuSchool of Electrical and Electronics Engineering, SASTRA Deemed University, Thanjavur, 613401, India.

Funding

Department of Science & Technology - SERB CRG/2022/008050
6 · The paper itself

Abstract

This paper focuses on designing and developing novel architectures termed Hybrid Vision UNet-Encoder Decoder (HVU-ED) segmenter and Hybrid Vision UNet-Encoder (HVU-E) classifier for brain tumor segmentation and classification, respectively. The proposed model integrates the powerful feature extraction capabilities of hybrid methods like ResNet50, VGG16, Dense121 and Xception with Vision Transformer(ViT). These extracted hybrid features are fused with UNet features in the bottleneck and are passed to the HVU-ED decoder path for the segmentation task. In HVU-E, same features fed as input to the classification layer and machine learning algorithms such as SVM, RF, DT, Logistic Regression and AdaBoost. The proposed DenseVU-ED model obtained the highest segmentation accuracy of 98.91% with the BraTS2020 dataset. The highest dice score of 0.902 for the enhanced tumor, 0.954 for the core tumor, and 0.966 for the whole tumor were obtained. The DenseVU-E classifier achieved the highest accuracy of 99.18% with neural network classification and 92.21% accuracy with SVM on Figshare dataset. Grad-CAM, SHAP, and LIME techniques provide model interpretability, highlighting the models' focus on significant brain areas and decision-making transparency. The proposed models outperform existing methods in segmentation and classification tasks.

Indexed as

Brain NeoplasmsImage Processing, Computer-AssistedAlgorithmsHumansMachine LearningMagnetic Resonance ImagingNeural Networks, ComputerSupport Vector Machine

Identifiers

PMID40610748
PMCPMC12229522

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.